| Follow-up and Steroid Treatment Results in Intussusception (NCT05640375) | Baskent University | 2019-12-24 |
| Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers (NCT04159961) | Daewoong Pharmaceutical Co. LTD. | 2019-12-24 |
| Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months (NCT04467541) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2019-12-24 |
| Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema (NCT04156191) | Arcutis Biotherapeutics, Inc. | 2019-12-23 |
| Clinical and Basic Research on the Treatment of Polycystic Ovary Syndrome (NCT04120597) | Jiangxi University of Traditional Chinese Medicine | 2019-12-23 |
| Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia (NCT04150887) | OncoVerity, Inc. | 2019-12-23 |
| Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma (NCT04270929) | Roger Williams Medical Center | 2019-12-23 |
| Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04051827) | Millennium Pharmaceuticals, Inc. | 2019-12-23 |
| A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread (NCT04147247) | Boehringer Ingelheim | 2019-12-23 |
| Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma (NCT04155749) | Kite, A Gilead Company | 2019-12-23 |
| A Drug Interaction Study of ACH-0145228 (NCT04709081) | Alexion Pharmaceuticals, Inc. | 2019-12-22 |
| CLR 131 Combined With Radiation for Head and Neck Cancer (NCT04105543) | University of Wisconsin, Madison | 2019-12-20 |
| Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial (NCT04413214) | Shanghai Jiao Tong University School of Medicine | 2019-12-20 |
| Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers (NCT04206657) | Kyowa Kirin Co., Ltd. | 2019-12-20 |
| Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) (NCT04170153) | EMD Serono Research & Development Institute, Inc. | 2019-12-20 |
| Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors (NCT04172454) | Akeso | 2019-12-20 |
| Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma (NCT04091503) | Center Trials & Treatment Europe | 2019-12-20 |
| A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males (NCT04183517) | Syntara | 2019-12-20 |
| WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases (NCT04197934) | Mayo Clinic | 2019-12-20 |
| Use of Oxandrolone to Promote Growth in Infants With HLHS (NCT04090697) | Carelon Research | 2019-12-20 |
| A Study to Assess the Effects of Itraconazole and Etravirine on JNJ-64417184 in Healthy Adult Participants (NCT04208373) | Janssen Research & Development, LLC | 2019-12-20 |
| Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED) (NCT03298815) | University of Utah | 2019-12-20 |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer (NCT04071262) | Eli Lilly and Company | 2019-12-20 |
| T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignancies and Hodgkin Lymphoma (NCT04160195) | National Cancer Institute (NCI) | 2019-12-20 |
| Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox® (NCT04402762) | Indonesia University | 2019-12-20 |
| A Study of Live Biotherapeutic Product MRx0518 With Hypofractionated Radiation Therapy in Resectable Pancreatic Cancer (NCT04193904) | 4D pharma plc | 2019-12-20 |
| PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) (NCT04382898) | BioNTech SE | 2019-12-19 |
| A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors. (NCT04209465) | Black Diamond Therapeutics, Inc. | 2019-12-19 |
| A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Balovaptan in Children With Autism Spectrum Disorder (NCT04049578) | Hoffmann-La Roche | 2019-12-19 |
| Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects (NCT05500820) | AstraZeneca | 2019-12-19 |
| TWB-103 for Treating Lower Limb Ulcers on Patients With DM (NCT03624023) | Transwell Biotech Co., Ltd. | 2019-12-19 |
| First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration (NCT04246866) | Gemini Therapeutics, Inc. | 2019-12-19 |
| KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A) (NCT04165070) | Merck Sharp & Dohme LLC | 2019-12-19 |
| Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers (NCT04225052) | Yuhan Corporation | 2019-12-19 |
| Study to Evaluate the Pharmacokinetics and Safety of EXPAREL Administered as a Pectoral Plane Block in Women Undergoing Breast Augmentation (NCT04293809) | Pacira Pharmaceuticals, Inc | 2019-12-19 |
| Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma (NCT04204941) | Epizyme, Inc. | 2019-12-19 |
| CMV-TCR-T Cells for CM Virus Infection After HSCT (NCT04153279) | Hebei Yanda Ludaopei Hospital | 2019-12-19 |
| A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers (NCT04126668) | AnewPharma | 2019-12-19 |
| A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma (NCT04200963) | Ikena Oncology | 2019-12-18 |
| CM082 in Patients With Myopic Choroidal Neovascularization (CNV) (NCT04222842) | AnewPharma | 2019-12-18 |
| A Study of Darunavir in Combination With Cobicistat or Ritonavir, and Dabigatran Etexilate in Healthy Participants (NCT04208061) | Janssen Research & Development, LLC | 2019-12-18 |
| Delayed Infusion of DCreg in Living Donor Liver Transplantation (NCT04208919) | Angus W. Thomson PhD DSc | 2019-12-18 |
| MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors (NCT04262739) | Haim Bio Co., Ltd. | 2019-12-18 |
| Study on the Safety of the Drug BAY2395840 at Different Doses, the Way the Body Absorbs, Distributes and Excretes the Drug Including the Effect of Its Formulation (Tablet or Liquid) and the Effect of Food on the Absorption, Distribution or Excretion of the Drug in Healthy Male Participants (NCT05517746) | Bayer | 2019-12-18 |
| A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) (NCT03740724) | Castle Creek Biosciences, LLC. | 2019-12-18 |
| Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma (NCT04091126) | GlaxoSmithKline | 2019-12-18 |
| The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects (NCT04201275) | Sunshine Lake Pharma Co., Ltd. | 2019-12-18 |
| A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants (NCT04202497) | Takeda | 2019-12-18 |
| Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Metformin (NCT04231435) | Celgene | 2019-12-18 |
| A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT04143802) | Eli Lilly and Company | 2019-12-18 |
| Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT04140487) | M.D. Anderson Cancer Center | 2019-12-17 |
| A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711 (NCT04135820) | Beta Pharma, Inc. | 2019-12-17 |
| A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants (NCT04185051) | Janssen Research & Development, LLC | 2019-12-17 |
| A Study of Newly Formulated Tylenol Tablet (Acetaminophen) and Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants (NCT04214691) | Janssen Korea, Ltd., Korea | 2019-12-17 |
| Pharmacokinetic Drug-Drug Interaction Study Between K-877 and CSG452 in Healthy Adult Volunteers (NCT04237597) | Kowa Research Institute, Inc. | 2019-12-17 |
| A Phase 1 Safety Study of Dengusiil in Healthy Adults (NCT04035278) | Serum Institute of India Pvt. Ltd. | 2019-12-17 |
| A Clinical Trial to Determine the Safety and Immunogenicity of Healthy Candidate MERS-CoV Vaccine (MERS002) (NCT04170829) | King Abdullah International Medical Research Center | 2019-12-17 |
| Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) (NCT04185883) | Amgen | 2019-12-17 |
| ANG-3070 in Healthy Adult Participants (NCT04196179) | Angion Biomedica Corp | 2019-12-17 |
| A Clinical Study Trial of Phenlarmide in China (NCT04164121) | Yiling Pharmaceutical Inc. | 2019-12-17 |
| An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants (NCT04176367) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2019-12-17 |
| Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine (NCT04349553) | Prokarium Ltd | 2019-12-16 |
| A Study to Evaluate LY01011 and Xgeva® in Healthy Adults (NCT04198636) | Luye Pharma Group Ltd. | 2019-12-16 |
| A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors (NCT04214093) | AstraZeneca | 2019-12-16 |
| A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma (NCT04194801) | CStone Pharmaceuticals | 2019-12-16 |
| Brain Imaging in Tobacco Smokers During a Quit Attempt (NCT04055467) | Johns Hopkins University | 2019-12-16 |
| A Study to Compare a Single-dose of Two Different Formulations of ACT-709478 in Healthy Men (NCT04123288) | Idorsia Pharmaceuticals Ltd. | 2019-12-16 |
| Supplementation of Oil Palm Phenolics to Healthy Participants (NCT04164446) | National University of Malaysia | 2019-12-16 |
| Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults (NCT05345912) | CrystalGenomics, Inc. | 2019-12-16 |
| Pharmacokinetic and Tolerance Study of Meloxicam Eye Drops in Healthy Volunteers (NCT04322175) | Beijing Tongren Hospital | 2019-12-16 |
| Anakinra as a Rescue Treatment for Allergic Inflammation (NCT04035109) | University of North Carolina, Chapel Hill | 2019-12-16 |
| A Research Study Looking at the Comparability (Bioequivalence) of Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity (NCT04187300) | Novo Nordisk A/S | 2019-12-16 |
| Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors (NCT04151810) | Dragonboat Biopharmaceutical Company Limited | 2019-12-16 |
| Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease (NCT04201574) | Allysta Pharmaceutical | 2019-12-16 |
| A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis (NCT04176198) | Sumitomo Pharma America, Inc. | 2019-12-16 |
| Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects (NCT04200261) | Sihuan Pharmaceutical Holdings Group Ltd. | 2019-12-16 |
| A Single Ascending Dose Trial of CVL-936 in Healthy Subjects (NCT04232878) | Cerevel Therapeutics, LLC | 2019-12-16 |
| Bioavailability of Levoketoconazole and Ketoconazole Tablets (NCT04212000) | Cortendo AB | 2019-12-16 |
| A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants (NCT04231513) | Eisai Inc. | 2019-12-16 |
| Near InfraRed Fluorescence Using Indocyanine Green and Magnetic Resonance Lymphography of Lymphatic Transport (NCT04046146) | University of Rochester | 2019-12-15 |
| Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease (NCT04097080) | Nobilis Therapeutics Inc. | 2019-12-15 |
| Dose Escalation Safety Study of TMB-365 in HIV-1 Infected Participants (NCT04027387) | TaiMed Biologics Inc. | 2019-12-14 |
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets (NCT04145583) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2019-12-14 |
| A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101 (NCT04111666) | Alector Inc. | 2019-12-14 |
| Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (III) (NCT04185805) | Daewoong Pharmaceutical Co. LTD. | 2019-12-14 |
| Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer (NCT04202601) | Peking University | 2019-12-13 |
| APR-246 in Combination With Venetoclax and Azacitidine in TP53-Mutant Myeloid Malignancies (NCT04214860) | Aprea Therapeutics | 2019-12-13 |
| A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With Famotidine (NCT04179071) | AstraZeneca | 2019-12-13 |
| A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors (NCT04200404) | CStone Pharmaceuticals | 2019-12-13 |
| Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity (NCT04199351) | Amgen | 2019-12-13 |
| Effects of Oxytocin on Cognitive and Reactive Fear (NCT04292444) | University Hospital, Bonn | 2019-12-13 |
| Chemoembolization for Lung Tumors (NCT04200417) | Memorial Sloan Kettering Cancer Center | 2019-12-13 |
| Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery (NCT04161755) | Memorial Sloan Kettering Cancer Center | 2019-12-13 |
| Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. (NCT04253145) | Fundacion Oncosur | 2019-12-13 |
| Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects (NCT05125640) | Joint Stock Company "Farmak" | 2019-12-13 |
| Safety and Tolerability of Oral Proglumide for NASH (NCT04152473) | Georgetown University | 2019-12-13 |
| Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. (NCT03767582) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-12-12 |
| Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers (NCT04161547) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2019-12-12 |
| Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior Therapies (NCT03546426) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2019-12-12 |
| Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer (NCT03941743) | Mayo Clinic | 2019-12-12 |